Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.
about
Elevated serum liver enzymes and fatty liver changes associated with long driving among taxi driversNon-alcoholic fatty liver disease and mortality among US adults: prospective cohort studyManagement of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseImmune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVObesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsPromising therapies for treatment of nonalcoholic steatohepatitis.Clinical predictors of incident gallstone disease in a Chinese population in Taipei, TaiwanLiver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.Gender and racial differences in nonalcoholic fatty liver disease.Non-Alcoholic Fatty Liver Disease Association with Cardiac ArrhythmiasNon-alcoholic fatty liver disease and cardiovascular risk.Withholding statins in patients with underlying liver disease: wise or unwise?Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TTriglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes.Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liverQuantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesAssociation between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese populationNonalcoholic fatty liver disease and aging: epidemiology to management.Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004.The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgeryOmega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial.Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients.Association between inflammatory markers and liver fat: The Multi-Ethnic Study of AtherosclerosisPNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease.Evaluation of dietary effects on hepatic lipids in high fat and placebo diet fed rats by in vivo MRS and LC-MS techniques.Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver DiseaseEthnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity.NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.Metabolic syndrome and hepatic resection: improving outcomeLongitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients.The Framingham risk score and heart disease in nonalcoholic fatty liver disease.Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysisBai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo.Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 peopleFatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality
P2860
Q23921831-BCCFBAE6-339B-47AC-9DA1-D07412D07C9EQ24596256-FDD7BF6C-A440-499F-A3B0-28003450C3C2Q26827665-69D5BB63-BA9C-451F-86A7-B0989FEA3735Q28079713-D28335FC-F026-4A40-A515-06EB5A3C27E4Q28079826-5216CC0F-FDA5-4EA4-9BAD-6A2B7EDF12E4Q28386598-8E62DF13-22CE-4FB4-884E-F0E1ED11516DQ30248578-D8F382A1-084E-468C-B0EC-1DCE7A1AA11DQ30438947-FA64B752-BD83-42DF-BCEE-275C5916C27CQ33640536-8C0406D1-58C5-40D6-A777-79601E1FAA4DQ33660001-65B9FCA5-901F-41C4-9D62-44A2EC8A485BQ33675914-22BA201A-5901-4D1A-96C6-C32C18F3C3DDQ33706265-AC82ABF3-1121-4231-B7FC-8A0BBF426DE0Q33763729-4A586EEB-109B-466D-BAAA-7206C9A8CCF3Q33787851-D4A30E0B-2CF5-4240-87D4-6F70BDC45160Q33932461-EB87D9B3-218A-4E85-9521-F49B943FDD8EQ33962221-789A9197-F901-4250-9199-38BE1BFAEE07Q34021973-92B98F59-8FE9-4261-9420-3D2A8D071C68Q34205386-F0D6918B-00FE-434D-90B8-2CCEA9CC0749Q34360938-2906732D-80FD-4E7A-8FD6-8B53F48DA350Q34366861-ACD678AA-1600-4E53-A552-5B377EA2113CQ34407496-6EE64EFB-2E22-41A3-B1AE-AC1330C1BC66Q34712540-E6CDF9E7-9853-40E3-96DC-EB828D206968Q34736255-D9B7C925-7C0B-460F-BC5C-FE1D7F6DB1C3Q34802683-33782741-04EF-4C13-9A40-30DDBBC10D76Q34976232-6BEC0A02-281E-4119-8AF8-408F0E35F653Q34998991-885B4CE0-499A-420F-AEA3-023D88AEDDBBQ35036094-B6BEF7FC-738D-4BF8-98F4-2FB993E87235Q35123226-20EBF856-8040-46D4-B76C-80306E8DAA9FQ35153538-A611E36C-A354-4D42-9A51-504EDF701A35Q35538949-42950E68-5562-4539-9201-E284EAEB07A7Q35553828-7165F7FA-8D02-4999-B3CE-75C04373C3A9Q35582273-89424DE6-85A3-4159-BDEE-3B1FCC58BCDEQ35629684-2350E797-3B57-4126-A154-3CA88948F025Q35705464-9DDD1B1B-5CAD-4F0F-B168-DE84195D1B94Q35946523-BA8D5350-ADF9-4D69-9B00-2F31783FA6B6Q35989623-F8B71939-7256-451A-9C30-762A865A63D9Q36134867-DA3DDB5A-AD3E-4362-8545-6BC3BBEAD10EQ36174315-9D0C5F03-5E55-4973-B057-0BBC6436881EQ36334667-BB687504-5C79-49D5-A566-74E2AD785ACDQ36401621-86A7C84A-91D7-42BC-95C7-F76A7BC2D3EF
P2860
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Suspected nonalcoholic fatty l ...... population-based cohort study.
@en
type
label
Suspected nonalcoholic fatty l ...... population-based cohort study.
@en
prefLabel
Suspected nonalcoholic fatty l ...... population-based cohort study.
@en
P2093
P2860
P1476
Suspected nonalcoholic fatty l ...... population-based cohort study
@en
P2093
Christopher Rogers
Deborah L Wingard
Paul Angulo
Ronghui Xu
Winston Dunn
Zobair M Younossi
P2860
P304
P356
10.1111/J.1572-0241.2008.02034.X
P407
P577
2008-08-05T00:00:00Z